Samsung Terbinafine Tablet (Terbinafine Hydrochloride)
Terbinafine Hydrochloride
Prescription medication
Samsung Pharmaceutical Co., Ltd.
MFDS item code 200400228 · Notified 2004.10.08
This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of onychomycosis, cutaneous fungal infections (tinea pedis, etc.), and tinea capitis in children
This medication is used for the treatment of skin fungal infections caused by dermatophytes, such as athlete's foot, body ringworm, and jock itch, as well as for nail fungal infections in adults. It is effective for treating tinea capitis in children. In summary, it helps improve various fungal infections occurring on the skin and nails.
Administer terbinafine 125 mg per dose twice daily or 250 mg per dose once daily. The duration of administration according to the condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Usually administer for 6 weeks~3 months. In cases of infection of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. A 3-month treatment period is usually sufficient for toenail infections, although treatment may take 6 months or longer in some patients. The treatment period may be longer in patients with slow nail growth. In patients with creatinine clearance less than 50 mL/min, reduce the daily dose by 1/2.
Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with administration in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be given regularly for the appropriate prescribed duration. Body weight less than 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with treatment is limited, the decision to administer should be made after considering the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. Body weight greater than 40 kg (over 12 years): Administer 250 mg per dose once daily.
This drug is not recommended for patients with liver dysfunction or a history of liver disease. Liver function tests must be performed before administration, and liver function should be regularly monitored during treatment. If symptoms of liver dysfunction (e.g., nausea, vomiting, fatigue, jaundice) occur, you should immediately notify your physician and discontinue the medication. This drug should not be used in patients with blood disorders, severe renal failure, nursing women, children under 2 years of age, or certain genetically predisposed lactose intolerant patients. In patients with reduced kidney function, the elderly, and smaller children, careful administration is required, and if skin rashes or serious skin reactions occur, treatment should be discontinued immediately. This medication can cause adverse reactions in various areas, including the liver, blood, skin, and muscles, so if symptoms appear, you should consult medical staff immediately. Caution is advisable when driving or operating machinery as dizziness may occur as a side effect. There may be interactions with other medications when taken together, so it is essential to inform your healthcare provider of any medications currently being taken, and dose adjustments may be necessary. Women who are pregnant or may become pregnant should use this drug cautiously after consulting a physician, and nursing mothers are advised to discontinue breastfeeding. Particular caution is needed for children and the elderly, and patients' conditions should be closely monitored before and after administration. In cases of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may occur; you should immediately inform medical staff and seek appropriate treatment. This medication should be kept out of children's reach and stored at room temperature, avoiding direct sunlight.
Persistent nausea, decreased appetite, fatigue, vomiting, upper right abdominal pain, jaundice, dark urine, loose stools, biliary tract failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, lethargy, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, skin hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, skin-mucosa syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, vesicular dermatitis, psoriasis-like rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, joint pain, muscle pain, muscle pain, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, hives, erythema, facial swelling, lymphangiectasia, gastrointestinal symptoms, abdominal distension, decreased appetite, dyspepsia, nausea, mild abdominal pain, diarrhea, discomfort in the upper abdomen, thirst, vomiting, glossitis, depression, anxiety, headache, taste disorder, dizziness, drowsiness, sensory abnormality, sensory loss, decreased attention, insomnia, elevated BUN, frequency of urination, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol in the blood, elevated triglycerides, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased visual acuity, hearing loss, auditory impairment, vasculitis, permanent loss of smell, hyposmia, drug rash with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a well-closed container that is air-tight, ideally at temperatures between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy and prevent degradation.
White round tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Terbinafine Hydrochloride
Prescription medication
Samsung Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.